Article
20 May 2025
Commissioner Makary Charts A New Course For FDA At FDLI Annual Conference
AUTHORS CONTENT
Article
14 May 2025
Knock Knock. Who's There? (Or Quién Es? Or Qui Est-ce? Or Wer Ist Es?) Surprise, It's FDA!
Article
24 Apr 2025
Reports Document FDA Review Delays: What Drugmakers Should Know Now
Article
14 Apr 2025
While FDA Suffers Staffing Cuts, Nondelegation Case In SCOTUS Is Latest Legal Challenge To Curb Agency Powers
Article
28 Feb 2025
In Uncertain Times, Good Compliance And Quality Communication Habits Can Offer A Port In The Storm
Article
05 Feb 2025
FOIA Requires Transparency Of Instructions To FDA Staff, Even When Those Instructions Are To Pause Communications With The Public
Article
05 Feb 2025
What We're Watching For In The Senate Confirmation Hearings To Consider Robert F. Kennedy, Jr. To Be Secretary Of HHS
Article
21 Nov 2024
GAO Report Recommends Retaining FDA's Drug Inspectional Workforce As Agency Prepares For Trumpian Changes
Article
07 Nov 2024
From The Porcine To The Ridiculous To The Court Of Appeals: Phibro's Suit Against FDA Gets Muddy
Article
07 Nov 2024
As Jurisprudence Under Loper Bright Develops, Early Scorecard Is Mixed
Article
30 Oct 2024
Homeopathic Industry Group Wants Court To Exclude It From FDA's Enforcement Plans
Article
29 Jan 2024
CDER's Office Of Compliance Kicks Off Annual Report Season With Rundown Of 2023's Major Public Health Enforcement Initiatives
Article
24 Jan 2024
From The Porcine To The Ridiculous: Veterinary Drugmaker Sues FDA For Alleged APA Violations
Article
11 Jan 2024
Regulatory Due Diligence Becomes More Critical In A "Hot" Year For Deals In The FDA Space
Article
22 Nov 2023
Going To 11: New Subsections At CDER's Office Of Pharmaceutical Quality Are Important Piece Of FDA's Inspection And Enforcement Strategy